BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27980399)

  • 1. Clinical factors and comorbidities affecting the cost of hospital-treated COPD.
    Deniz S; Şengül A; Aydemir Y; Çeldir Emre J; Özhan MH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3023-3030. PubMed ID: 27980399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
    Ornek T; Tor M; Altın R; Atalay F; Geredeli E; Soylu O; Erboy F
    Int J Med Sci; 2012; 9(4):285-90. PubMed ID: 22701335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization.
    Terzano C; Colamesta V; Unim B; Romani S; Meneghini A; Volpe G; La Torre G
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3680-3689. PubMed ID: 28925473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
    Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS; Shukla A; Müllerova H
    Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET.
    Byng D; Lutter JI; Wacker ME; Jörres RA; Liu X; Karrasch S; Schulz H; Vogelmeier C; Holle R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1423-1439. PubMed ID: 31308648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to high-cost hospital care for patients with COPD.
    Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
    Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.
    Ngo CQ; Thi Bui T; Vu GV; Chu HT; Phan PT; Ngoc Pham H; Vu GT; Nguyen LH; Ha GH; Tran BX; Latkin CA; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30598020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.
    Souliotis K; Kousoulakou H; Hillas G; Tzanakis N; Toumbis M; Vassilakopoulos T
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1395-1400. PubMed ID: 28546747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score.
    Diamantea F; Kostikas K; Bartziokas K; Karakontaki F; Tsikrika S; Pouriki S; Polychronopoulos V; Karagiannidis N; Haniotou A; Papaioannou AI
    Respir Care; 2014 Nov; 59(11):1679-86. PubMed ID: 24962226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender.
    Sánchez-Muñoz G; Lopez-de-Andrés A; Hernández-Barrera V; Jiménez-García R; Pedraza-Serrano F; Puente-Maestu L; de Miguel-Díez J
    PLoS One; 2019; 14(1):e0211222. PubMed ID: 30682190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
    Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
    Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.